• 1
    Committee on Quality of Health Care in America and Institute of Medicine. To Err is Human—Building a Safer Health System. Washington DC: National Academy Press 1999.
  • 2
    Department of Health. An Organisation with a Memory. London: Department of Health 2000.
  • 3
    Winterstein AG, Sauer BC, Hepler CD, Poole C. Preventable drug-related hospital admissions. Ann Pharmacother 2002; 36: 123848.
  • 4
    Beijer HJM, De Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002; 24: 4654.
  • 5
    Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients. Bandolier Extra 2002; June: 115.
  • 6
    Joint Formulary Committee. British National Formulary, 48th edn, London: British Medical Association and The Royal Pharmaceutical Society of Great Britain 2004.
  • 7
    Hallas J, Haghfelt T, Gram LF, Grodum E, Damsbo N. Drug related admissions to a cardiology department; frequency and avoidability. J Intern Med 1990; 228: 37984.
  • 8
    Hallas J, Jensen KB, Grodum E, Damsbo N, Gram LF. Drug related admissions to a department of medical gastroenterology. Scand J Gastroenterol 1991; 26: 17480.
  • 9
    Hallas J, Harvald B, Gram LF, Grodum E, Brosen K, Haghfelt T, Damsbo N. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990; 228: 8390.
  • 10
    Hallas J, Davidsen O, Grodum E, Damsbo N, Gram LF. Drug-related illness as a cause of admission to a department of respiratory medicine. Respiration 1992; 59: 304.
  • 11
    Hallas J, Worm J, Beck-Nielsen J, Gram LF, Grodum E, Damsbo N, Brosen K. Drug related events and drug utilization in patients admitted to a geriatric hospital department. Dan Med Bull 1991; 38: 41720.
  • 12
    Hallas J, Gram LF, Grodum E, Damsbo N, Brosen K, Haghfelt T, Harvald B, Beck-Nielsen J, Worm J, Jensen KB, Davidsen O, Frandsen NE, Hagen C, Andersen M, Frolund F, Kromann-Andersen H, Schou J. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992; 33: 618.
  • 13
    Hallas J, Harvald B, Worm J, Beck-Nielsen J, Gram LF, Grodum E, Damsbo N, Schou J, Kromann-Andersen H, Frolund F. Drug related hospital admissions. Results from an intervention programme. Eur J Clin Pharmacol 1993; 45: 199203.
  • 14
    Cunningham G, Dodd TRP, Grant DJ, McMurdo MET, Richards RME. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997; 26: 37582.
  • 15
    Howard RL, Avery AJ, Howard PD, Partridge M. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care 2003; 12: 2805.
  • 16
    Green CF, Mottram DR, Rowe PH, Pirmohamed M. Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study. J Clin Pharm Ther 2000; 25: 35561.
  • 17
    Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21: 294300.
  • 18
    Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 159.
  • 19
    Bigby J, Dunn J, Goldman L, Adams JB, Jen P, Landefeld CS, Komaroff AL. Assessing the preventability of emergency hospital admissions. A method for evaluating the quality of medical care in a primary care facility. Am J Med 1987; 83: 10316.
  • 20
    Lakshmanan MC, Hershey CO, Bresalau D. Hospital admissions caused by iatrogenic disease. Arch Intern Med 1986; 146: 19314.
  • 21
    Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med 2001; 31: 199205.
  • 22
    Dartnell JG, Anderson RP, Chohan V, Galbraith KJ, Lyon MEH, Nestor PJ, Moulds RFW. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust 1996; 164: 65962.
  • 23
    Courtman BJ, Stallings SB. Characterisation of drug-related problems in elderly patients on admissions to a medical ward. Can J Hosp Pharm 1995; 48: 1616.
  • 24
    Raschetti R, Morgutti M, Menniti-Ippolito F, Belisari A, Rossignoli A, Longhini P, La Guidara C. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 1999; 54: 95963.
  • 25
    Howard RL, Avery AJ, Morris CJ. Using chart review and clinical databases to study medical error. In: Patient Safety: Research Into Practice, eds WalsheK, BoadenR. Maidenhead: Open University Press 2006: 11829.
  • 26
    Jha AK, Kuperman GJ, Rittenberg E, Teich JM, Bates DW. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepi Drug Saf 2001; 10: 1139.
  • 27
    McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002; 36: 13316.
  • 28
    Health and Social Care Information Centre. Prescription Cost Analysis: England 2004. Leeds: Health and Social Care Information Centre 2005 (last accessed: 11 April 2006).
  • 29
    Huerta C, Castellsague J, Varas-Lorenzo C, Rodriguez LAG. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis 2005; 45: 5319.
  • 30
    Hawkey CJ, Langman MJS. Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors. Gut 2003; 52: 6008.
  • 31
    Lai CK, Lam SK, Chu KM, Wong BYC, Hui WM, Hu WHC, Lau GKK, Wong WM, Yuen MF, Chan AOO, Lai CL, Wong J. Lansoprazole for the prevention on recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002; 26: 20338.
  • 32
    Blue L, Lang E, McMurray JJV, Davie AP, McDonagh TA, Murdoch DR, Petrie MC, Connolly E, Norrie J, Round CE, Ford I, Morrison CE. Randomised controlled trial of specialist nurse intervention in heart failure. BMJ 2001; 323: 7158.
  • 33
    Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D’Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996; 348: 4238.
  • 34
    Garg AX, Adhikari NKJ, McDonald H, Rosas-Arellano MP, Devereaux PJ, Beyene J, Sam J, Haynes RB. Effects of a computerized clinical decisions support systems on practitioner performance and patient outcomes. JAMA 2005; 293: 122338.
  • 35
    Avery AJ, Savelyich BS, Sheikh A, Cantrill J, Morris CJ, Fernando B, Bainbridge M, Horsfield P, Teasdale S. Identifying and establishing consensus on the most important safety features of GP computer systems: e-Delphi study. Inform Prim Care 2005; 13: 312.